The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Deborah Rund

Hematology Department

Hadassah University Hospital

Jerusalem

Israel 91120

[email]@cc.huji.ac.il

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Hematology Department, Hadassah University Hospital, Jerusalem, Israel 91120. 1998 - 2009
  • Plasmapheresis Unit, Department of Hematology, Hadassah University Hospital, Ein Kerem, Israel. 2007

References

  1. Multidrug resistance in myeloma: seeing the whole picture. Rund, D. Leuk. Lymphoma (2009) [Pubmed]
  2. 'Rapping' on the door of drug resistance. Rund, D. Leuk. Lymphoma (2009) [Pubmed]
  3. Genetic modifiers in hemoglobinopathies. Rund, D., Fucharoen, S. Curr. Mol. Med. (2008) [Pubmed]
  4. Plasma exchange as treatment for Lawsone (henna) intoxication. Rund, D., Schaap, T., Da'as, N., Ben Yehuda, D., Kalish, J. J. Clin. Apher (2007) [Pubmed]
  5. Hyperforin modulation of drug resistance: saint or sinner? Rund, D. Leuk. Lymphoma (2007) [Pubmed]
  6. Multidrug resistance in lymphoma: is it time for clinical trials?. Rund, D. Leuk. Lymphoma (2007) [Pubmed]
  7. FLT3 internal tandem duplication in low risk MDS: clinical and basic science relevance. Rund, D. Leuk. Lymphoma (2007) [Pubmed]
  8. Beta-thalassemia. Rund, D., Rachmilewitz, E. N. Engl. J. Med. (2005) [Pubmed]
  9. Therapy-related leukemia: clinical characteristics and analysis of new molecular risk factors in 96 adult patients. Rund, D., Krichevsky, S., Bar-Cohen, S., Goldschmidt, N., Kedmi, M., Malik, E., Gural, A., Shafran-Tikva, S., Ben-Neriah, S., Ben-Yehuda, D. Leukemia (2005) [Pubmed]
  10. Therapy-related leukemia and myelodysplasia: evolving concepts of pathogenesis and treatment. Rund, D., Ben-Yehuda, D. Hematology (2004) [Pubmed]
  11. An unexpectedly high frequency of heterozygosity for alpha-thalassemia in Ashkenazi Jews. Rund, D., Filon, D., Jackson, N., Asher, N., Oron-Karni, V., Sacha, T., Czekalska, S., Oppenheim, A. Blood Cells Mol. Dis. (2004) [Pubmed]
  12. New trends in the treatment of beta-thalassemia. Rund, D., Rachmilewitz, E. Crit. Rev. Oncol. Hematol. (2000) [Pubmed]
  13. Alpha-globin mutations and rearrangements in Israel. PCR-based analysis reveals ethnic diversity. Rund, D., Oron-Karni, V., Filon, D., Oppenheim, A. Ann. N. Y. Acad. Sci. (1998) [Pubmed]
  14. Heme arginate therapy for beta thalassemia: in vitro versus in vivo effects. Rund, D., Fibach, E., Goldfarb, A., Friedberg, A., Rachmilewitz, E. Acta Haematol. (1998) [Pubmed]
 
WikiGenes - Universities